RecruitingNCT06236373

The Unmet Needs of Cancer Survivors in Ausl IRCCS Reggio Emilia

The Unmet Needs of Cancer Survivors in Ausl IRCCS Reggio Emilia Reality: a Qualitative Study and Framework Analysis


Sponsor

University of Modena and Reggio Emilia

Enrollment

45 participants

Start Date

Apr 20, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

This qualitative study seeks to explore the unmet needs of individuals who have recently undergone a cancer diagnosis and completed the acute phase of treatment. The primary objective is to utilize the experiences of patients, caregivers, and stakeholders to enhance the aftercare provided to cancer survivors. By delving into patient perceptions regarding unmet needs in cancer aftercare, the study aims to identify areas for redesigning and improving services to minimize these needs and ultimately enhance patient outcomes. Importantly, the investigation incorporates insights from patients, their caregivers, and stakeholders. The research will employ qualitative methods, specifically focus groups and interviews, to gather comprehensive perspectives from individuals in the Ausl IRCCS Reggio Emilia district who have completed treatment for breast, prostate, colorectal, thyroid, and multiple myeloma cancers. Including patients with diverse cancer types is crucial for capturing a broad spectrum of experiences. During data collection, both focus group discussions and interviews will be recorded in audio format and transcribed verbatim. This meticulous approach ensures an accurate representation of participants' voices and experiences. The subsequent analysis will employ a combination of framework and thematic analysis to extract meaningful insights and synthesize the data effectively. The study's ultimate goal is to leverage the findings to optimize aftercare services for cancer survivors within the local context of Ausl IRCCS Reggio Emilia. By incorporating the perspectives of patients, caregivers, and stakeholders, the research aims to contribute valuable insights that can inform the redesign and improvement of aftercare services, ultimately benefitting cancer survivors in the region.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This qualitative study is gathering information from cancer survivors, their caregivers, and healthcare stakeholders to understand what unmet needs remain after completing active cancer treatment. No experimental treatment is involved. **You may be eligible if...** - You are 18 or older - You are a survivor of breast, prostate, thyroid, colorectal, multiple myeloma, or lymphoma cancer who has completed the main phase of treatment and is now in follow-up or on maintenance treatment - OR you are a caregiver or a healthcare stakeholder supporting someone who meets the above criteria - You can communicate in Italian **You may NOT be eligible if...** - You do not wish to participate - You do not speak or understand Italian - You have significant cognitive or communication difficulties Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERFocus Groups or Interviews

Focus groups and qualitative interview will be conducted with patients, caregivers and stake-holders trying to identify unmet needs of cancer survivors after the acute treatment phase. Individual interviews (in presence or online) will be hold as alternative if it will not be possible (due to logistical or personal problems) to participate in a focus group or if the number of people who would have agreed to participate in that focus group is less than 3


Locations(1)

Casa della Salute ex Spallanzani

Reggio Emilia, Reggio Emilia, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06236373


Related Trials